Table 3.
Relationship between LINC02195 expression and clinical parameters of patients in TCGA.
| Clinical parameter | n | LINC02195 expression in TCGA database | ||
|---|---|---|---|---|
| Mean ± SED | t | P | ||
| Tumor vs. Normal | ||||
| Adjacent non-tumor tissue | 44 | 5.68 ± 0.9405 | 4.123 | <0.0001* |
| Tumor | 502 | 21.66 ± 1.143 | ||
| Age (years) | ||||
| <60 | 245 | 21.73 ± 1.782 | 0.1238 | 0.9016 |
| ≥60 | 255 | 21.44 ± 1.458 | ||
| Sex | ||||
| Male | 367 | 21.81 ± 1.354 | 0.2262 | 0.8211 |
| Female | 134 | 21.22 ± 2.149 | ||
| Pathological grade | ||||
| G1+G2 | 362 | 20.48 ± 1.3 | 1.402 | 0.1616 |
| G3+G4 | 120 | 24.12 ± 2.234 | ||
| Pathological stage | ||||
| Stage I-II | 95 | 22.93 ± 2.487 | 0.7006 | 0.4840 |
| Stage III-IV | 338 | 20.89 ± 1.377 | ||
| T | ||||
| T1+T2 | 178 | 22.58 ± 1.823 | 0.9838 | 0.3258 |
| T2+T3 | 267 | 20.22 ± 1.538 | ||
| N | ||||
| N0 | 170 | 21.13 ± 1.793 | 0.2114 | 0.8327 |
| N1+N2+N3 | 238 | 21.66 ± 1.706 | ||